Table 4.
Association of TERT promoter C228T mutation with BRAF V600E mutation in PTC
TERT C228T mutation (n/N (%)) |
BRAF V600E mutation (n/N (%)) |
|||||
---|---|---|---|---|---|---|
Tumor type | BRAF− | BRAF+ | P valuea | TERT− | TERT+ | P valuea |
PTC | 11/153 (7.2) | 19/104 (18.3) | 0.0094 | 85/227 (37.4) | 19/30 (63.3) | 0.0094 |
ATC | 20/44 (45.5) | 5/10 (50.0) | 1.0 | 5/29 (17.2) | 5/25 (20.0) | 1.0 |
PTC, papillary thyroid cancer; ATC, anaplastic thyroid cancer.
Per two-tailed Fisher's exact test.